EMEA-002424-PIP02-19
Key facts
| Active substance |
7-(2-Methoxy-3,5-dimethylpyridin-4-yl)-1-[(3S)-tetrahydrofuran-3-yl]-1,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one maleate
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0354/2019
|
| PIP number |
EMEA-002424-PIP02-19
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of dementia with Lewy bodies
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Eisai Ltd
E-mail: lmedInfo@eisai.net |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|